PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

Similar documents
TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

Award Number: W81XWH

Fort Detrick, Maryland

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

Award Number: W81XWH

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

Approved for public release; distribution unlimited

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

Approved for public release; distribution unlimited

Detection of Prostate Cancer Progression by Serum DNA Integrity

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

CONTRACTING ORGANIZATION: Texas A&M Health Science Center Temple, TX 76504

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

Promote Adjustment during Reintegration following Deployment

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: MIPR 3GD3DN3081. TITLE: Outcomes of Telehealth Group Psychosocial Interventions for Breast Cancer Patients and Their Partners

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

CONTRACTING ORGANIZATION: Cleveland Clinic Foundation Cleveland, OH 44195

TITLE: Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls. Rachel Novotny, Ph.D. Honolulu, HI 96822

TITLE: Mission Connect Mild TBI Translational Research Consortium. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: A Tissue Engineering Approach to Study the Progression of Breast Tumor Metastasis in Bone

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Interchromosomal Associations that Alter NF1 Gene Expression Can Modify Clinical Manifestations of Neurofibromatosis 1. Palo Alto, CA 94304

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer

CONTRACTING ORGANIZATION: University of Texas M.D. Anderson Cancer Center Houston, TX 77030

Award Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

Expression and Promoter Methylation of P16INK4A During Estrogen-Induced Mammary Carcinogenesis in the ACI Rat. Omaha, NE

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

TITLE: A PSCA Promoter Based Avian Retroviral Transgene Model of Normal and Malignant Prostate

TITLE: Investigating the Role of TBX2 in the Inhibition of Senescence in Prostate Cancer

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

TITLE: Prostate Expression Databases: Gene Expression Resources for Comparative Studies of Prostate Carcinogenesis

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

TITLE: The Role of HOX Proteins in Androgen-Independent Prostate Cancer

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

TITLE: Genetic and epigenetic biomarkers for recurrent prostate cancer after radiotherapy

TITLE: Selective Oncolytic Therapy for Hypoxic Breast Cancer Cells. CONTRACTING ORGANIZATION: Ordway Research Institute Albany, New York 12208

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

Transcription:

AD (Leave blank) Award Number: W81XWH-07-1-0244 TITLE: The Root Cause of Post-traumatic and Developmental Stress Disorder PRINCIPAL INVESTIGATOR: Keith A. Young, PhD CONTRACTING ORGANIZATION: Texas A&M University System Health Science Center College Station, TX 77854 REPORT DATE: May 2008 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: (Check one) X Approved for public release; distribution unlimited Distribution limited to U.S. Government agencies only; report contains proprietary information The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. Young Page 1

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE (DD-MM-YYYY) 3. DATES COVERED (From - To) 2. REPORT TYPE Annual Y1 (07-08) 01/05/2008 4. TITLE AND SUBTITLE The Root Cause of Post-traumatic and Developmental Stress Disorder 1 March 2007-28 Feb 2008 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-07-1-0244 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Keith A. Young, PhD 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER Texas A&M University System Health Science Center College Station, Texas 77843 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) U.S. Army Medical Research and Materiel Command Fort Detrick, MD 21702 10. SPONSOR/MONITOR S ACRONYM(S) MOMRP 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT 13. SUPPLEMENTARY NOTES Approved for public release. Distribution unlimited. 14. ABSTRACT Our overarching scientific hypothesis holds that serotonergic influences on brain development driven by genetics and early experience induce a variation of normal brain anatomy that makes the brain highly susceptible to the effects of severe stress. We are studying this question using both clinical and basic approaches. Full funding of the main contract and subcontracts was completed in August of 2007, and equipment purchases and setup was completed in the following 3 months. Set-up work to validate the assays and procedures have been largely completed. In the ½ year since full funding, local IRB submissions have been made for projects 1 (PTSD screen in active duty troops), 2 (Fluoxetine treatment of active duty troops) and 5 (MRI and psychophysiological assessments). An additional funding supplement to project 5, which will extend the MRI patient recruitment to include active duty troops at Fort Hood using a newly acquired mobile 3T MRI (provided by the VA) has received funding as part of an additional FY2007-2008 funding supplement. The IRB submission for this supplement to project 5 has also been submitted, and a change in scope has been submitted to MOMRP for review. IRB submission for project 4 (Post-mortem analysis) is in preparation. Approval to proceed with animal work was received in August and at this date, most animals enrolled in Task 1 and 2 have completed the protocol. Initial behavioral analysis indicates that both pre- and post-natal isolation stress alters the behavior of adult animals. Histological and stereological work on the brains from these animals is now in progress to complete these tasks. 15. SUBJECT TERMS No subject terms provided. 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U c. THIS PAGE U UU 18. NUMBER OF PAGES 7 19a. NAME OF RESPONSIBLE PERSON USAMRMC 19b. TELEPHONE NUMBER (include area code) Young Page 2 Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std. Z39.18

Table of Contents Page Introduction..... 4 Body.. 5 Key Research Accomplishments... 5 Reportable Outcomes 7 Conclusion 7 References. N/A Appendices N/A Young Page 3

INTRODUCTION: Our overarching scientific hypothesis holds that serotonergic influences on brain development driven by genetics and early experience induce a variation of normal brain anatomy that makes the brain highly susceptible to the effects of severe stress. The goal of Project 1 is to describe the progression of post-deployment stress disorders (PTSD, major depression, suicidality) in active duty troops, and to investigate developmental and environmental factors that influence predisposition to PTSD and depression. In coordination with this effort, we will implement a therapeutic trial of the serotonin reuptake inhibitor fluoxetine, to determine whether it can alter the trajectory of post-deployment PTSD (Project 2: This proposal is funded by CDMRP). Using DNA gathered from Projects 1 and 2 (and 5), Project 3 will investigate genetic factors influencing resiliency and susceptibility to stress disorders and therapeutic response to fluoxetine. Projects 4 and 5 are designed to elucidate basic relationships between genetic variation in the serotonin system, limbic brain anatomy, brain function and behavior. Project 4 will investigate post-mortem anatomy in subjects with major depression, while Project 5 will investigate anatomical and functional brain changes in subjects exposed to varying levels of chronic and traumatic stress. An additional supplement to project 5, which will extend the MRI patient recruitment to include active duty troops at Fort Hood using a newly acquired mobile 3T MRI has received funding as part of an additional FY2007-2008 supplement. Finally, animal models (Project 6) will be used to investigate the development of the brain anatomical stress susceptibility phenotype and to screen for novel agents with potential to treat PTSD and depression. An overarching goal of the Program is integration of data across the projects to compare and contrast the potential for different assessment paradigms (MRI anatomy, fmri, evoked potentials, startle, genetic profiling) to screen for resiliency and predisposition to posttraumatic and developmental stress disorder stress disorders. Young Page 4

BODY: KEY RESEARCH ACCOMPLISHMENTS: Administrative: Full funding of the main contract and subcontracts was completed in August of 2007, and equipment purchases and setup was completed in the following 3 months. Approval to proceed with animal work was received from the Animal Care and Use Review Office in August. In the ½ year since full funding, IRB submissions have been made for projects 1 (PTSD screen in active duty troops), 2 (Fluoxetine treatment of active duty troops) and 5 (MRI and psychophysiological assessments). An additional supplement to project 5, which will extend the MRI patient recruitment to include active duty troops at Fort Hood using a newly acquired mobile 3T MRI has received funding as part of an additional FY2007-2008 supplement. The IRB submission for this supplement to project 5 has also been submitted, and the change in scope has been submitted to MOMRP for review. IRB submission for project 4 (Post-mortem analysis) is in preparation. Project Specific: Project 1 Early progression of post-deployment stress disorders (phase 1: post-deployment) Task 1: Sample 1400 active duty/guard troops < 6 wks post-deployment a. CAPS/depression symptoms b. Stress battery (DRRI, development history, suicidality) c. DNA, cortisol d. RBANS (cognitive screen) Task 2: Resample/test at ~ 6mo Task 3: Follow-up contact at 1 year for pathways to mental health care. 1a Deliverable: Progression of stress disorder in post-deployment troops 1b Deliverable: Multiple genetic and psychosocial factors alter the trajectory of military PTSD 2a Deliverable: Postdeployment pathways to mental healthcare Awaiting IRB approval Project 2 Fluoxetine for post-deployment stress disorder Task 1: Fluoxetine/placebo supplementation of standard of care in active duty troops (mo 5-40) Task 2: Open label fluoxetine extension Task 3: Exploratory analysis of factors contributing to fluoxetine response No deliverables: funded by PDMRP (awaiting IRB approval) Project 3 Serotonin and other genes and biomarkers Task 1: Compare biologic factors: susceptible vs. resilient (Project 1) and treatment responsive vs. nonresponsive (Project 2) a. SERT-ss vs. SERT-sl/ll b. Biomarkers 3a Deliverable: SERT-ss genotype predicts response to traumatic stress Task 2: Serotonin and additional genes 3b Deliverable: Serotonin pathway gene alleles contribute to 5HTTLPR effects on PTSD Task 3: Multi-locus analysis 3c Deliverable: Factors affecting fluoxetine response in treatment of PTSD symptoms New staff to perform the sample storage, DNA extraction and analysis for this Aim have been hired and trained. Storage of DNA on DNA cards has been tested and compared to extraction for blood and brain samples using existing de-identified samples. DNA extracted from blood samples yielded cleaner PCR that was more stable at different DNA storage times, and provided more total DNA for additional genotyping. Because of this improvement, we will use venous blood sampling rather than DNA cards or cheek swabs in the study. A new SERT assay yielding additional SERT variants was tested and compared to the older PCR procedure. The new assay yielded the same S/L calls as the original assay and will be used in the Young Page 5

experiment, since it provides additional information on genetic variation in the SERT gene. Additional assays for BDNF, COMT, HTR1A and FKBP5 are currently being piloted. Project 4 Serotonin and other genetic effects on cellular level brain anatomy. Task 1. Compare regional volumes and neuronal populations in SERT-ss vs. sl/ll 4a Deliverable: 5HTTLPR effects on the thalamic/cingulate ratio. Task 2. Compare serotonin fiber density in SERT-ss vs. SERT-sl/ll thalamus 4b Deliverable: 5HTTLPR effects on thalamic and cingulate serotonin fiber density. This project is the final protocol for this project to be submitted for IRB approval. We are preparing the protocol for submission within the next 3 months. Project 5 Serotonin and other genetic effects on regional brain anatomy and function Task 1: Compare thalamic anatomy and startle/evoked potentials in controls and PTSD with SERT as a cofactor. 5a Deliverable: Thalamic enlargement and startle in PTSD. 5b1 Deliverable: 5HTTLPR short allele is associated with thalamic enlargement and potentiated baseline startle. (NEW aim in 2008) 5b2 : Thalamic enlargement and startle in PTSD in active duty troops Task 2: Compare effect of emotional probes on startle/evoked potentials in normal controls and PTSD 5c Deliverable: Facial fear effects on startle and evoked potentials are potentiated in subjects with the 5HTTLPR short allele. New staff has been hired and training has been completed to perform MRI and psychophysiological data analysis. Equipment to obtain psychophysiological testing has been purchased and set-up is complete. Equipment to perform new aim # 5b2 (MRI assessment in active duty troops) has been designed and purchased. The mobile 3T MRI delivery and pad site at Fort Hood should be completed in 2008 allowing this additional work to be performed in active duty troops. A change in scope to perform this additional work as part of project 5 has been submitted to MOMRP. Using existing, de-identified 3T MRI data from a previous project, we compared thalamic manual outlining procedures to automated segmentation routines (Primarily Freesurfer). The automated procedures were very inaccurate at identifying the ventrolateral borders of the thalamus, and resulted in considerably more variability in thalamic volumes than the manual procedures. Until a better automated procedure is available for thalamic and other subcortical structures, we will continue to manually segment the thalamus and use the segmentation routines to for cortical volume estimation only. Available SERT genotypes for these existing samples provided initial evidence that SERT genetic variations may significantly affect thalamic volumes. Since new software designed specifically for 3T images are expected to be available soon, we will continue to test new products that may allow us to reduce MRI analysis times. Young Page 6

Project 6 Anatomical and behavioral animal models of developmental stress disorders Task 1: Develop relevant rodent models a. Developmental environmental effects on thalamic/cingulate anatomy, behavior and electrophysiology a1. Prenatal stress 6a Deliverable: Prenatal stress reduces the cingulate/thalamic volume ratio and potentiates adult depressive and aggressive behavior. a2. Postnatal stress 6b Deliverable: Early post-natal stress reduces the cingulate/thalamic volume ratio and potentiates adult depressive and aggressive behavior b. Developmental serotonergic effects on thalamic/cingulate anatomy, behavior and electrophysiology 6c Deliverable: Prenatal elevation of serotonin levels reduces the cingulate/thalamic volume ratio and potentiates adult depressive and aggressive behavior Task 2: Use rodent model(s) as screens a. Effect of the anatomical brain stress phenotype on ETOH intake 6d Deliverable: Prenatal stress accentuates ETOH intake and reduces adversive effects of high dose ETOH b. Preclinical testing for PTSD agents 6e Deliverable: Effect of peritraumatic and adult administration of fluoxetine on development of long-term behavioral patterns in rats New staff has been hired and training to perform animal model development and data analysis. Equipment perform the animal testing has been purchased and set-up is complete. Currently, deliverable 6a and 6b (prenatal and post-natal stress models) are partially completed. Behavioral testing has been completed and the brains are being prepared for histology and stereology. Initial analysis of behavior alone suggests that the early developmental interventions altered behavior. We will complete the histological analysis before proceeding to 6c and Task 2. REPORTABLE OUTCOMES: None CONCLUSION: No scientific conclusions have been made at this point in time. APPENDICES: None. Young Page 7